Shandong Lukang Pharmaceutical Co.,Ltd. provided earnings guidance for the full year of fiscal 2013. The company announced according to preliminary statistics of its financial department, the company will turn losses into gains in its business performance in 2013 compared with that in the same period of the year before, with the net profit belonging to shareholders of the company to be between RMB 7 million and RMB 11 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.79 CNY | -1.02% | -10.46% | +9.10% |
May. 29 | China Approves Lukang Pharma's Anti-Asthma Injection | MT |
Apr. 23 | Shandong Lukang Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.10% | 964M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- 600789 Stock
- News Shandong Lukang Pharmaceutical Co.,Ltd.
- Shandong Lukang Pharmaceutical Co.,Ltd. Provides Earnings Guidance for the Full Year of Fiscal 2013